Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8

BACKGROUND: Cut-offs on self-report depression screening tools are designed to identify many more people than those who meet criteria for major depressive disorder. In a recent analysis of the European Health Interview Survey (EHIS), the percentage of participants with Patient Health Questionnaire-8...

Full description

Bibliographic Details
Published in:BMJ Mental Health
Main Authors: Fischer, Felix, Zocholl, Dario, Rauch, Geraldine, Levis, Brooke, Benedetti, Andrea, Thombs, Brett, Rose, Matthias, Kostoulas, Polychronis
Format: Text
Language:English
Published: BMJ Publishing Group 2023
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083787/
http://www.ncbi.nlm.nih.gov/pubmed/37024144
https://doi.org/10.1136/bmjment-2023-300675
id ftpubmed:oai:pubmedcentral.nih.gov:10083787
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:10083787 2023-09-26T15:19:23+02:00 Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8 Fischer, Felix Zocholl, Dario Rauch, Geraldine Levis, Brooke Benedetti, Andrea Thombs, Brett Rose, Matthias Kostoulas, Polychronis 2023-04-05 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083787/ http://www.ncbi.nlm.nih.gov/pubmed/37024144 https://doi.org/10.1136/bmjment-2023-300675 en eng BMJ Publishing Group http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083787/ http://www.ncbi.nlm.nih.gov/pubmed/37024144 http://dx.doi.org/10.1136/bmjment-2023-300675 © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . BMJ Ment Health Original Research Text 2023 ftpubmed https://doi.org/10.1136/bmjment-2023-300675 2023-08-27T00:49:41Z BACKGROUND: Cut-offs on self-report depression screening tools are designed to identify many more people than those who meet criteria for major depressive disorder. In a recent analysis of the European Health Interview Survey (EHIS), the percentage of participants with Patient Health Questionnaire-8 (PHQ-8) scores ≥10 was reported as major depression prevalence. OBJECTIVE: We used a Bayesian framework to re-analyse EHIS PHQ-8 data, accounting for the imperfect diagnostic accuracy of the PHQ-8. METHODS: The EHIS is a cross-sectional, population-based survey in 27 countries across Europe with 258 888 participants from the general population. We incorporated evidence from a comprehensive individual participant data meta-analysis on the accuracy of the PHQ-8 cut-off of ≥10. We evaluated the joint posterior distribution to estimate the major depression prevalence, prevalence differences between countries and compared with previous EHIS results. FINDINGS: Overall, major depression prevalence was 2.1% (95% credible interval (CrI) 1.0% to 3.8%). Mean posterior prevalence estimates ranged from 0.6% (0.0% to 1.9%) in the Czech Republic to 4.2% (0.2% to 11.3%) in Iceland. Accounting for the imperfect diagnostic accuracy resulted in insufficient power to establish prevalence differences. 76.4% (38.0% to 96.0%) of observed positive tests were estimated to be false positives. Prevalence was lower than the 6.4% (95% CI 6.2% to 6.5%) estimated previously. CONCLUSIONS: Prevalence estimation needs to account for imperfect diagnostic accuracy. CLINICAL IMPLICATIONS: Major depression prevalence in European countries is likely lower than previously reported on the basis of the EHIS survey. Text Iceland PubMed Central (PMC) BMJ Mental Health 26 1 e300675
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Original Research
spellingShingle Original Research
Fischer, Felix
Zocholl, Dario
Rauch, Geraldine
Levis, Brooke
Benedetti, Andrea
Thombs, Brett
Rose, Matthias
Kostoulas, Polychronis
Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8
topic_facet Original Research
description BACKGROUND: Cut-offs on self-report depression screening tools are designed to identify many more people than those who meet criteria for major depressive disorder. In a recent analysis of the European Health Interview Survey (EHIS), the percentage of participants with Patient Health Questionnaire-8 (PHQ-8) scores ≥10 was reported as major depression prevalence. OBJECTIVE: We used a Bayesian framework to re-analyse EHIS PHQ-8 data, accounting for the imperfect diagnostic accuracy of the PHQ-8. METHODS: The EHIS is a cross-sectional, population-based survey in 27 countries across Europe with 258 888 participants from the general population. We incorporated evidence from a comprehensive individual participant data meta-analysis on the accuracy of the PHQ-8 cut-off of ≥10. We evaluated the joint posterior distribution to estimate the major depression prevalence, prevalence differences between countries and compared with previous EHIS results. FINDINGS: Overall, major depression prevalence was 2.1% (95% credible interval (CrI) 1.0% to 3.8%). Mean posterior prevalence estimates ranged from 0.6% (0.0% to 1.9%) in the Czech Republic to 4.2% (0.2% to 11.3%) in Iceland. Accounting for the imperfect diagnostic accuracy resulted in insufficient power to establish prevalence differences. 76.4% (38.0% to 96.0%) of observed positive tests were estimated to be false positives. Prevalence was lower than the 6.4% (95% CI 6.2% to 6.5%) estimated previously. CONCLUSIONS: Prevalence estimation needs to account for imperfect diagnostic accuracy. CLINICAL IMPLICATIONS: Major depression prevalence in European countries is likely lower than previously reported on the basis of the EHIS survey.
format Text
author Fischer, Felix
Zocholl, Dario
Rauch, Geraldine
Levis, Brooke
Benedetti, Andrea
Thombs, Brett
Rose, Matthias
Kostoulas, Polychronis
author_facet Fischer, Felix
Zocholl, Dario
Rauch, Geraldine
Levis, Brooke
Benedetti, Andrea
Thombs, Brett
Rose, Matthias
Kostoulas, Polychronis
author_sort Fischer, Felix
title Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8
title_short Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8
title_full Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8
title_fullStr Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8
title_full_unstemmed Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8
title_sort prevalence estimates of major depressive disorder in 27 european countries from the european health interview survey: accounting for imperfect diagnostic accuracy of the phq-8
publisher BMJ Publishing Group
publishDate 2023
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083787/
http://www.ncbi.nlm.nih.gov/pubmed/37024144
https://doi.org/10.1136/bmjment-2023-300675
genre Iceland
genre_facet Iceland
op_source BMJ Ment Health
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083787/
http://www.ncbi.nlm.nih.gov/pubmed/37024144
http://dx.doi.org/10.1136/bmjment-2023-300675
op_rights © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. Published by BMJ.
https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
op_doi https://doi.org/10.1136/bmjment-2023-300675
container_title BMJ Mental Health
container_volume 26
container_issue 1
container_start_page e300675
_version_ 1778142670869233664